Delivery Order SPE2DB22D3011-SPE2DB25FQ1BE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,029.95 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Chloraseptic Sore Throat Lozenges (18-count package). This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.30 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages). Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,119.84 for Chloraseptic sore throat lozenges (18-count). This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. The order will be performed in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Chloraseptic Max 15-10 mg lozenges in quantities of 15 units. This is a firm fixed-price delivery order with a ceiling value of $2,636.76 and an ultimate completion date of August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count) under a firm fixed-price contract valued at $3,864.64, with an ultimate completion date of September 18, 2025. This non-set-aside award was issued competitively and represents a single delivery order for over-the-counter throat lozenges to support federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count packages) with a ceiling value of $3,021.03. This competitively awarded, non-set-aside contract employs firm fixed price pricing and is scheduled for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $3,452.36 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 19, 2025, for Chloraseptic Sore 18s products. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ1BEDelivery Order
The Defense Logistics Agency awarded a $1,290.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages) on June 2, 2025, with an ultimate completion date of June 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency and U.S. Coast Guard operations worldwide. This delivery order for over-the-counter throat lozenges exemplifies the company's versatility in fulfilling both specialized and routine medical supply needs through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/2/25 |